icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Five years of Treatment with Tenofovir DF for Chronic Hepatitis B Infection is Associated with Sustained Viral Suppression and Significant Regression of Histological Fibrosis and Cirrhosis
 
 
  Reported by Jules Levin
AASLD Nov 5-9 2011 SF
 
P. Marcellin1, M. Buti2, E.J. Gane3, Z. Krastev4, R. Flisiak5, G. Germanidis6, M.K. Washington7, C.N. Barnes8, J.F. Flaherty8, J.D. Bornstein8, J.G. McHutchison8, E.J. Heathcote9 1H˘pital Beaujon, APHP, Clichy, France, 2Hospital General Universitari Vall d'Hebron and Ciberehd, Barcelona, Spain, 3Auckland City Hospital, Auckland, New Zealand ,4University Hospital "St. Ivan Rilsky", Sofi a, Bulgaria, 5Medical University of Bialystok, Bialystok, Poland, 6University Hospital of Thessaloniki, Thessaloniki, Greece, 7Vanderbilt University, Nashville, TN, United States, 8Gilead Sciences Inc., Foster City, CA, United States, 9University of Toronto, Toronto, ON, Canada

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif